Curexo

At a glance

Curexo filed 38 disclosures in the last 12 months, including 5 insider, 2 5% holder, 1 contract and 1 issuance. The most recent key filing was on Jun 8.

Revenue for 2025 was ₩74.5B, up 34.2% on 2024. Operating margin was 3.2% against -10.5% a year earlier. Debt was 5% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩39.7B and operating profit of ₩1.5B.

The 2025 annual report lists 103 employees with an average tenure of 5.1 years and average pay of ₩62.9M, #847 of 1,829 listed companies by average pay. Its 7 directors and auditors were paid ₩81M each on average. It paid no cash dividend for 2025. (주)에치와이 and related parties held 30.94% at year end.

From the 2025 annual report

Staff: 103 (79 men, 24 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩6.5B. Directors and auditors: 7, paid ₩568M in total.

No cash dividend was paid for 2025.

Largest shareholder

(주)에치와이 holds 30.94%; with 0 related parties the group holds 30.94% of common shares at year end.

Auditor: 한영회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary